Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade

A 69‐year‐old man with non‐small cell lung cancer presenting with pericardial effusion and rapid progression of dyspnea achieved long‐term disease stabilization after radiation therapy and immunotherapy. This case shows that pembrolizumab may improve prognosis in advanced lung cancer, even when comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Tsuyoshi, Matsubara, Hirochika, Muto, Mamoru, Sasanuma, Harunobu, Sugimura, Saya, Onuki, Yuichiro, Nakajima, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795085/
https://www.ncbi.nlm.nih.gov/pubmed/36590662
http://dx.doi.org/10.1002/ccr3.6795
_version_ 1784860177218928640
author Uchida, Tsuyoshi
Matsubara, Hirochika
Muto, Mamoru
Sasanuma, Harunobu
Sugimura, Saya
Onuki, Yuichiro
Nakajima, Hiroyuki
author_facet Uchida, Tsuyoshi
Matsubara, Hirochika
Muto, Mamoru
Sasanuma, Harunobu
Sugimura, Saya
Onuki, Yuichiro
Nakajima, Hiroyuki
author_sort Uchida, Tsuyoshi
collection PubMed
description A 69‐year‐old man with non‐small cell lung cancer presenting with pericardial effusion and rapid progression of dyspnea achieved long‐term disease stabilization after radiation therapy and immunotherapy. This case shows that pembrolizumab may improve prognosis in advanced lung cancer, even when complicated by cardiac tamponade.
format Online
Article
Text
id pubmed-9795085
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97950852022-12-30 Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade Uchida, Tsuyoshi Matsubara, Hirochika Muto, Mamoru Sasanuma, Harunobu Sugimura, Saya Onuki, Yuichiro Nakajima, Hiroyuki Clin Case Rep Case Report A 69‐year‐old man with non‐small cell lung cancer presenting with pericardial effusion and rapid progression of dyspnea achieved long‐term disease stabilization after radiation therapy and immunotherapy. This case shows that pembrolizumab may improve prognosis in advanced lung cancer, even when complicated by cardiac tamponade. John Wiley and Sons Inc. 2022-12-27 /pmc/articles/PMC9795085/ /pubmed/36590662 http://dx.doi.org/10.1002/ccr3.6795 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Uchida, Tsuyoshi
Matsubara, Hirochika
Muto, Mamoru
Sasanuma, Harunobu
Sugimura, Saya
Onuki, Yuichiro
Nakajima, Hiroyuki
Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
title Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
title_full Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
title_fullStr Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
title_full_unstemmed Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
title_short Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
title_sort long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795085/
https://www.ncbi.nlm.nih.gov/pubmed/36590662
http://dx.doi.org/10.1002/ccr3.6795
work_keys_str_mv AT uchidatsuyoshi longtermsurvivalofapatientwithlungcancertreatedwithpembrolizumabafterrecurrentcardiactamponade
AT matsubarahirochika longtermsurvivalofapatientwithlungcancertreatedwithpembrolizumabafterrecurrentcardiactamponade
AT mutomamoru longtermsurvivalofapatientwithlungcancertreatedwithpembrolizumabafterrecurrentcardiactamponade
AT sasanumaharunobu longtermsurvivalofapatientwithlungcancertreatedwithpembrolizumabafterrecurrentcardiactamponade
AT sugimurasaya longtermsurvivalofapatientwithlungcancertreatedwithpembrolizumabafterrecurrentcardiactamponade
AT onukiyuichiro longtermsurvivalofapatientwithlungcancertreatedwithpembrolizumabafterrecurrentcardiactamponade
AT nakajimahiroyuki longtermsurvivalofapatientwithlungcancertreatedwithpembrolizumabafterrecurrentcardiactamponade

Ejemplares similares